IgA Nephropathy (IgAN): Pathology & Diagnosis | Dr. Jonathan Zeckerman | UCLA GN Symposium 2026

I Have a Rare Kidney Disease | IgA Nephropathy

Phase 3 VISIONARY: Can Selectively Blocking Cytokine APRIL Slow Kidney Decline in #IgAN?

New Treatment for IgA nephropathy #shorts #igan #filspari #ckd #kidneydisease

IgA Nephropathy (IgAN): Evolving Management Strategies | Dr. Lama Abdelnour | UCLA GN 2026

IgA Nephropathy Treatment- New Drugs #shorts #ckd #iganephropathy #igan #nephropathy

#Telitacicept slows #kidney damage in #IgAN #news #kidneyhealth #nephropathy #pharma #vorbio

2025 update on what's happening in IgA Nephropathy

Otsuka’s Sibeprenlimab Shows ‘Impressive’ Proteinuria Reduction in Phase III IgAN Trial

How Do We Manage IgA Nephropathy? A Case-Based Approach | Dr. Mohammad Kamgar | UCLA GN 2026

VISIONARY Trial Explained: Sibeprenlimab (Voyxact) IgA Nephropathy | Landmark Trials in Nephrology

IgA Nephropathy Is Not a Death Sentence #IgANephropathy #KidneyDisease #KidneyHealth #IgAN

IgA Nephropathy (IgAN): Pathophysiology, Disease Mechanisms | UCLA GN Symposium 2026

Meet Sean: Living with IgA Nephropathy

PREVAIL: Felzartamab’s Sustained Clinical Outcomes In IgAN, With Jurgen Floege, MD

“IgA Can Live With Me” | Living With IgA Nephropathy

Atacicept FDA-approved July 7, 2026 for IgA Nephropathy

Watch Drs. Appel & Kelepouris discuss #IgAN updates at #RPA2026: https://bit.ly/2026IgAN-Y

Highlights from the 18th International IgA Nephropathy Symposium (IIgANN 2025), Prague

ALIGN Trial Explained: Atrasentan (Vanrafia) for IgA Nephropathy | Landmark Trials in Nephrology

Creatinine 2.69 in IgA Nephropathy – What Should You Do?

NefIgArd Trial Explained: Nefecon for IgA Nephropathy | Landmark Trials in Nephrology

Accelerated Approval for Atrasentan in IgAN

TARPEYO Reduces the Loss of Kidney Function in IgA Nephropathy

Sibeprenlimab: Mechanism of Action Explained | 1st FDA-Approved APRIL Inhibitor for IgA Nephropathy

Brain Fog Tips: How I Stay Organized Every Day #IgANephropathy #IgAN #kidneydisease #brainfog

Dana Rizk on APPLAUSE-IgAN

Let's talk potassium when living with #iganephropathy

Tarpeyo (Budesonide) Is Transforming IgA Nephropathy Care with FDA’s Full Approval

Finerenone Shows Promise in IgAN: Reduced Proteinuria, Stable Kidney Function.

Ig A Nephropathy #shorts #igan #ckd #proteinuria #hematuria

PROTECT Trial Explained: Sparsentan for IgA Nephropathy | Landmark Trials in Nephrology

Crohn's disease and IgA nephropathy

🫴 Finding community in the #igan Foundation helped confront a rare disease diagnosis

Understanding Atrasentan (Vanrafia) for IgA Nephropathy, with Richard Lafayette, MD

One New Drug for 3 Rare Diseases? The Truth About Iptacopan!